Engineered gadolinium-based nanomaterials as cancer imaging agents
Source abstract
Abstract
Abstract Gadolinium (Gd) based nanoparticles have been employed for magnetic resonance imaging (MRI) and computed tomography (CT) imaging due to the specific paramagnetic property and the high X-ray attenuation coefficient of Gd. Similarly to Gd, other elements (e.g., gold)-based nanocomposites have been applied to optical imaging, CT imaging, and other imaging modalities. By combining the strengths of these elements, Gd hybrids-based nanocomposites have been prepared for multi-modal imaging by tuning the size, shape, composition, and surface functionalization/coating. These nanosystems may be further loaded with imaging probes, nucleic acids, anticancer drugs, photosensitizers, and other functional moieties to accurately delineate the cancerous tissue, specifically deliver therapeutic agents to eliminate tumor cells and real-time monitor cellular responses to these drugs. To best of our knowledge, there is no systematical review of Gd-hybrid-based nanocomposites. Herein, we summarize advances in preparation and engineering of Gd and its hybrid-based nanocomposites for cancer imaging and highlight challenges in synthesis and application of these nanoscale agents. Importantly, their toxicity issues and engineering strategies to reduce their toxicity are elaborated. Clinical translation of Gd-based hybrid nanocomposites into practices could be realized from joint efforts of interdisciplinary scientists.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Lanthanide and Transition Metal Complexes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review10.1016/S0168-3659(99)00248-5 ↗
2. Tunable Hydrophile-Lipophile Balance for Manipulating Structural Stability and Tumor Retention of Amphiphilic Nanoparticles10.1002/adma.201901586 ↗
3. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy10.1038/s41565-019-0485-z ↗
4. Ligand-Installed Nanocarriers toward Precision Therapy10.1002/adma.201902604 ↗
5. Initiator-Loaded Gold Nanocages as a Light-Induced Free-Radical Generator for Cancer Therapy10.1002/anie.201703159 ↗
6. A triple-collaborative strategy for high-performance tumor therapy by multifunctional mesoporous silica-coated gold nanorods10.1002/adfm.201505175 ↗
7. A multifunctional nanotheranostic for the intelligent MRI diagnosis and synergistic treatment of hypoxic tumor10.1016/j.biomaterials.2018.05.018 ↗
8. Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment10.1016/j.apsb.2018.09.001 ↗
9. Engineered paramagnetic graphene quantum dots with enhanced relaxivity for tumor imaging10.1021/acs.nanolett.8b04252 ↗
10. A comparative study of gadolinium based oxide and oxyfluoride glasses as low energy radiation shielding materials10.1016/j.pnucene.2016.12.014 ↗
11. Multifunctional efficiency: extending the concept of atom economy to functional nanomaterials10.1021/acsnano.8b00932 ↗
12. Advanced nanotechnology leading the way to multimodal imaging‐guided precision surgical therapy10.1002/adma.201904329 ↗
13. Gadolinium-based contrast agents: from gadolinium complexes to colloidal systems10.1016/j.ijpharm.2019.118577 ↗
14. Integrin αvβ3 Receptor Overexpressing on Tumor-Targeted Positive MRI-Guided Chemotherapy10.1021/acsami.9b16648 ↗
15. Ultrasmall NaGdF4 Nanodots for Efficient MR Angiography and Atherosclerotic Plaque Imaging10.1002/adma.201305222 ↗
16. Synergistic MicroRNA therapy in liver fibrotic rat using MRI-visible nanocarrier targeting hepatic stellate cells10.1002/advs.201801809 ↗
17. Magically magnetic gadolinium10.1038/nchem.2287 ↗
18. Tumor detection by nuclear magnetic resonance10.1126/science.171.3976.1151 ↗
19. Advances in clinical MRI technology10.1126/scitranslmed.aba2591 ↗
20. Polyoxometalate-based radiosensitization platform for treating hypoxic tumors by attenuating radioresistance and enhancing radiation response10.1021/acsnano.7b03037 ↗
21. Structure–relaxivity relationships of magnetic nanoparticles for magnetic resonance imaging10.1002/adma.201804567 ↗
22. A self‐assembled biocompatible nanoplatform for multimodal mr/fluorescence imaging assisted photothermal therapy and prognosis analysis10.1002/smll.201801612 ↗
23. Diverse applications of nanomedicine10.1021/acsnano.6b06040 ↗
24. Negative CT contrast agents for the diagnosis of malignant osteosarcoma10.1002/advs.201901214 ↗
25. Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies10.1016/j.addr.2016.09.001 ↗
26. Nano-sized CT contrast agents10.1002/adma.201300081 ↗
27. CT image contrast of high-Z elements: phantom imaging studies and clinical implications10.1148/radiol.2015150577 ↗
28. Bisphosphonate functionalized gadolinium oxide nanoparticles allow long‐term MRI/CT multimodal imaging of calcium phosphate bone cement10.1002/adhm.201800202 ↗
29. In vivo irreversible albumin-binding near-infrared dye conjugate as a naked-eye and fluorescence dual-mode imaging agent for lymph node tumor metastasis diagnosis10.1016/j.biomaterials.2019.119279 ↗
30. Dragonfly-shaped near-infrared AIEgen with optimal fluorescence brightness for precise image-guided cancer surgery10.1016/j.biomaterials.2020.120036 ↗
31. Near-IR emissive rare-earth nanoparticles for guided surgery10.7150/thno.40808 ↗
32. Gadolinium-doped carbon dots as nano-theranostic agents for MR/FL diagnosis and gene delivery10.1039/C9NR03988K ↗
33. Gd3+-ion-doped upconversion nanoprobes: relaxivity mechanism probing and sensitivity optimization10.1002/adfm.201201469 ↗
34. Cyanine based nanoprobes for cancer theranostics10.1002/adhm.201700262 ↗
35. Large-Scale High-Yield Synthesis of PdCu@Au tripods and the quantification of their luminescence properties for cancer cell imaging10.4028/www.scientific.net/JNanoR.49.85 ↗
36. Near-infrared light-excited upconverting persistent nanophosphors in vivo for imaging-guided cell therapy10.1021/acsami.8b05706 ↗
37. An intelligent nanoplatform for imaging-guided photodynamic/photothermal/chemo-therapy based on upconversion nanoparticles and CuS integrated black phosphorus10.1016/j.cej.2019.122822 ↗
38. Gold nanostructures: a class of multifunctional materials for biomedical applications10.1039/B821763G ↗
39. Controllable fabrication of Au nanocups by confined-space thermal dewetting for OCT imaging10.1002/adma.201701070 ↗
40. Gold nanoparticles in ophthalmology10.1002/med.21509 ↗
41. Uniformly Formed Gold Nanocubes with Ultrahigh Reproducibility in Single-Particle Scattering and Surface-Enhanced Raman Scattering10.1021/acs.nanolett.8b02973 ↗
42. Nanomedicine for spontaneous brain tumors: a companion clinical trial10.1021/acsnano.8b04406 ↗
43. Surface-enhanced Raman nanoparticles for tumor theranostics applications10.1016/j.apsb.2018.03.007 ↗
44. Dark-field microscopy studies of single metal nanoparticles: understanding the factors that influence the linewidth of the localized surface plasmon resonance10.1039/b714759g ↗
45. Dark-field microscopy studies of polarization-dependent plasmonic resonance of single gold nanorods: rainbow nanoparticles10.1039/c1nr10336a ↗
46. Contrast agents for molecular photoacoustic imaging10.1038/nmeth.3929 ↗
47. Salt-induced aggregation of gold nanoparticles for photoacoustic imaging and photothermal therapy of cancer10.1039/C6NR00056H ↗
48. Core–Satellite Nanomedicines for in Vivo Real-Time Monitoring of Enzyme-Activatable Drug Release by Fluorescence and Photoacoustic Dual-Modal Imaging10.1021/acsnano.8b05136 ↗
49. Gadolinium doping enhances the photoacoustic signal of synthetic melanin nanoparticles: a dual modality contrast agent for stem cell imaging10.1021/acs.chemmater.8b04333 ↗
50. CuS Nanotheranostic Agent for In Vivo Photoacoustic/Magnetic Resonance Imaging-Guided Tumor-Targeted Photothermal Therapy10.1021/acsnano.6b05760 ↗
51. Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications10.1021/cr980440x ↗
52. Evaluating the Patient with Reported Gadolinium-Associated Illness10.1007/s13181-018-0689-x ↗
53. Chemistry of MRI contrast agents: current challenges and new frontiers10.1021/acs.chemrev.8b00363 ↗
54. Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents10.1038/s41467-019-09342-3 ↗
55. Gadolinium Complex of 1, 4, 7, 10-Tetraazacyclododecane-1, 4, 7-trisacetic Acid (DO3A)–Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent10.1021/acs.jmedchem.7b00060 ↗
56. Crystal structures of DOTMA chelates from Ce3+ to Yb3+: evidence for a continuum of metal ion hydration states10.1002/chem.201902068 ↗
57. Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications10.1038/s41467-018-03315-8 ↗
58. (III)–Hemicryptophane Complex10.1021/acs.orglett.9b00081 ↗
59. Nanoscale metal–organic frameworks for therapeutic, imaging, and sensing applications10.1002/adma.201707634 ↗
60. Synthesis of metal–organic framework nanosheets with high relaxation rate and singlet oxygen yield10.1021/acs.chemmater.8b02467 ↗
61. H4octox: versatile bimodal octadentate acyclic chelating ligand for medicinal inorganic chemistry10.1021/jacs.8b09964 ↗
62. Biomineralized Gd2O3@ HSA nanoparticles as a versatile platform for dual‐modal imaging and chemo‐phototherapy‐synergized tumor ablation10.1002/adhm.201901005 ↗
63. Click” chemistry-tethered hyaluronic acid-based contact lens coatings improve lens wettability and lower protein adsorption10.1021/acsami.6b07433 ↗
64. A novel nitroreductase-enhanced MRI contrast agent and its potential application in bacterial imaging10.1016/j.apsb.2017.11.001 ↗
65. MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent10.1038/ncomms8984 ↗
66. Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics10.7150/thno.38069 ↗
67. Updated developments on molecular imaging and therapeutic strategies directed against necrosis10.1016/j.apsb.2019.02.002 ↗
68. Poly (alkylidenimine) dendrimers functionalized with the organometallic moiety [Ru (η5-C₅H₅)(PPh₃) ₂]+ as promising drugs against cisplatin-resistant cancer cells and human mesenchymal stem cells10.3390/molecules23061471 ↗
69. New anionic poly (alkylideneamine) dendrimers as microbicide agents against HIV-1 infection10.1039/C9NR00303G ↗
70. A nanostrategy for efficient imaging-guided antitumor therapy through a stimuli-responsive branched polymeric prodrug10.1002/advs.201903243 ↗
71. Safe and potent MRI contrast agents by complexing gadolinium with enzyme/reduction dual-sensitive branched polymers10.1016/j.apmt.2019.07.019 ↗
72. Tumor environment-responsive degradable branched glycopolymer magnetic resonance imaging contrast agent and its tumor-targeted imaging10.1166/jbn.2019.2759 ↗
73. Enzyme/pH-sensitive dendritic polymer-DOX conjugate for cancer treatment10.1007/s40843-018-9277-8 ↗
74. Functional L‐lysine dendritic macromolecules as liver‐imaging probes10.1002/mabi.200900231 ↗
75. Multifunctional gadolinium-based dendritic macromolecules as liver targeting imaging probes10.1016/j.biomaterials.2010.12.049 ↗
76. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents10.1016/j.biomaterials.2011.07.006 ↗
77. The potential of peptide dendron functionalized and gadolinium loaded mesoporous silica nanoparticles as magnetic resonance imaging contrast agents10.1039/C5TB02709H ↗
78. A dendronized heparin–gadolinium polymer self-assembled into a nanoscale system as a potential magnetic resonance imaging contrast agent10.1039/C6PY00059B ↗
79. Stimuli-responsive biodegradable hyperbranched polymer–gadolinium conjugates as efficient and biocompatible nanoscale magnetic resonance imaging contrast agents10.1021/acsami.6b00980 ↗
80. Enzyme-sensitive biodegradable and multifunctional polymeric conjugate as theranostic nanomedicine10.1016/j.apmt.2018.02.003 ↗
81. Gadolinium-labeled biodegradable dendron–hyaluronic acid hybrid and its subsequent application as a safe and efficient magnetic resonance imaging contrast agent10.1021/acsami.7b06496 ↗
82. Cross-linked and biodegradable polymeric system as a safe magnetic resonance imaging contrast agent10.1021/acsami.7b16345 ↗
83. Linear and core-crosslinked glycopolymer-gadolinium conjugates: preparation and their behaviors as nanoscale magnetic resonance imaging contrast agents10.1166/jbn.2019.2813 ↗
84. Reductive microenvironment responsive gadolinium-based polymers as potential safe MRI contrast agents10.1039/C8BM01103F ↗
85. Hepatocyte targeting and intracellular copper chelation by a thiol-containing glycocyclopeptide10.1021/ja106206z ↗
86. Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A. 1 cells10.1016/j.taap.2010.04.014 ↗
87. Emerging transporter-targeted nanoparticulate drug delivery systems10.1016/j.apsb.2018.10.005 ↗
88. A history of exploring cancer in context10.1038/s41568-018-0006-7 ↗
89. Chemodynamic therapy: tumour microenvironment‐mediated Fenton and Fenton‐like reactions10.1002/anie.201805664 ↗
90. Enzyme-Responsive Copolymer as a Theranostic Prodrug for Tumor In Vivo Imaging and Efficient Chemotherapy10.1166/jbn.2019.2833 ↗
91. Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy10.1016/j.biomaterials.2018.03.046 ↗
92. Development and application of hyaluronic acid in tumor targeting drug delivery10.1016/j.apsb.2019.06.004 ↗
93. A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancy10.1038/nnano.2016.72 ↗
94. Coordination-responsive longitudinal relaxation tuning as a versatile mri sensing protocol for malignancy targets10.1002/advs.201800021 ↗
95. Red-light-controlled release of drug–ru complex conjugates from metallopolymer micelles for phototherapy in hypoxic tumor environments10.1002/adfm.201804227 ↗
96. Cysteine cathepsins: multifunctional enzymes in cancer10.1038/nrc1949 ↗
97. Dendronized-Polymer Disturbing Cells’ Stress Protection by Targeting Metabolism Leads to Tumor Vulnerability10.1002/adma.201907490 ↗
98. Polyamidoamine and polyglycerol; their linear, dendritic and linear–dendritic architectures as anticancer drug delivery systems10.1039/C4TB02133A ↗
99. Development of an aptamer-conjugated polyrotaxane-based biodegradable magnetic resonance contrast agent for tumor-targeted imaging10.1021/acsabm.8b00639 ↗
100. Theranostic quercetin nanoparticle for treatment of hepatic fibrosis10.1021/acs.bioconjchem.9b00631 ↗